BrightPath Biotherapeutics Co., Ltd. Share Price
Equities
4594
JP3274140007
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
57 JPY | 0.00% | -3.39% | -34.48% |
Sales 2017 | 529M 3.38M 269M | Sales 2018 | 354M 2.26M 180M | Capitalization | 33.68B 215M 17.15B |
---|---|---|---|---|---|
Net income 2017 | -1.11B -7.11M -567M | Net income 2018 | -1.58B -10.08M -803M | EV / Sales 2017 | 34.8 x |
Net cash position 2017 | 4.95B 31.64M 2.52B | Net cash position 2018 | 6.53B 41.73M 3.32B | EV / Sales 2018 | 76.7 x |
P/E ratio 2017 |
-19.2
x | P/E ratio 2018 |
-19.5
x | Employees | 42 |
Yield 2017 * |
-
| Yield 2018 |
-
| Free-Float | 95.53% |
1 week | -3.39% | ||
Current month | -5.00% | ||
1 month | -5.00% | ||
3 months | -19.72% | ||
6 months | -50.00% | ||
Current year | -34.48% |
Managers | Title | Age | Since |
---|---|---|---|
Kenichi Nagai
CEO | Chief Executive Officer | 54 | 31/12/08 |
Director/Board Member | 55 | 30/04/16 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 77 | 31/05/15 | |
Akira Yamada
BRD | Director/Board Member | 67 | 30/04/03 |
Kenichi Nagai
CEO | Chief Executive Officer | 54 | 31/12/08 |
Date | Price | Change | Volume |
---|---|---|---|
14/05/24 | 57 | 0.00% | 116 100 |
13/05/24 | 57 | 0.00% | 248,600 |
10/05/24 | 57 | -1.72% | 447,500 |
09/05/24 | 58 | -1.69% | 285,600 |
08/05/24 | 59 | 0.00% | 205,500 |
Delayed Quote Japan Exchange, May 14, 2024 at 03:30 am
More quotes1st Jan change | Capi. | |
---|---|---|
-34.48% | 25.87M | |
+26.37% | 44.96B | |
-1.01% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+9.34% | 26.08B | |
-21.69% | 19.03B | |
+6.23% | 12.75B | |
+26.99% | 12.06B | |
-3.38% | 11.75B |
- Stock Market
- Equities
- 4594 Stock